Related Practice Life Sciences & Pharma This report highlights how biopharma executives should adapt to the evolving biopharma landscape in both the nearer and longer term. 01262022160113
Executive Insights Life Sciences & Pharma The Inflation Reduction Act: Implications for Drug Delivery Innovation January 3, 2024
Article Life Sciences & Pharma The New Map – Shifting geographic priorities for healthcare companies operating in Asia November 1, 2023